We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+21.99%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$137M
AUM Growth
+$6.74M
Cap. Flow
-$9.94M
Cap. Flow %
-7.27%
Top 10 Hldgs %
36.21%
Holding
88
New
23
Increased
19
Reduced
22
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 40.81%
2 Consumer Discretionary 12.34%
3 Communication Services 11.33%
4 Industrials 11.3%
5 Financials 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
26
Centene
CNC
$30.7B
$2.08M 1.52%
+80,000
New +$1.87M
DIS icon
27
Walt Disney
DIS
$167B
$2.07M 1.51%
22,000
-16,000
-42% -$1.44M
MPAA icon
28
Motorcar Parts of America
MPAA
$254M
$2.05M 1.5%
66,000
+23,000
+53% +$693K
HUM icon
29
Humana
HUM
$43.7B
$1.85M 1.35%
+12,900
New +$1.76M
RCPT
30
PUT
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.84M 1.34%
+15,000
New +$1.52M
BLUE
31
DELISTED
bluebird bio
BLUE
$1.79M 1.31%
+1,505
New +$1.01M
SAVE
32
DELISTED
Spirit Airlines, Inc.
SAVE
$1.74M 1.27%
+23,000
New +$1.65M
ACHC icon
33
Acadia Healthcare
ACHC
$2.76B
$1.71M 1.25%
28,000
+6,000
+27% +$349K
FOLD
34
DELISTED
Amicus Therapeutics
FOLD
$1.66M 1.22%
200,000
+70,000
+54% +$480K
PODD icon
35
Insulet
PODD
$11.5B
$1.66M 1.21%
36,000
+34,500
+2,300% +$1.48M
ZTS icon
36
Zoetis
ZTS
$32.4B
$1.64M 1.2%
+38,000
New +$1.54M
EHTH icon
37
eHealth
EHTH
$42.2M
$1.63M 1.19%
65,500
-500
-0.8% -$12.2K
AVDL
38
DELISTED
Avadel Pharmaceuticals
AVDL
$1.59M 1.16%
93,000
+31,000
+50% +$443K
ATRO icon
39
Astronics
ATRO
$3.43B
$1.55M 1.13%
51,101
+24,404
+91% +$645K
ANAC
40
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$1.53M 1.12%
47,500
-24,500
-34% -$735K
HNT
41
DELISTED
HEALTH NET INC
HNT
$1.49M 1.09%
27,900
-21,100
-43% -$1.04M
IBN icon
42
ICICI Bank
IBN
$108B
$1.39M 1.01%
132,000
-59,675
-31% -$609K
RDUS
43
DELISTED
Radius Health, Inc.
RDUS
$1.28M 0.94%
+33,000
New +$782K
CPAY icon
44
Corpay
CPAY
$25B
$1.19M 0.87%
+8,000
New +$1.15M
BMY icon
45
CALL
Bristol-Myers Squibb
BMY
$133B
$1.18M 0.86%
20,000
JAZZ icon
46
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.16M 0.85%
7,100
-6,900
-49% -$1.15M
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$121B
$1.13M 0.83%
9,500
-15,000
-61% -$1.69M
EVHC
48
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.07M 0.79%
10,354
ADPT
49
DELISTED
Adeptus Health Inc
ADPT
$1.05M 0.77%
+28,000
New +$881K
ALXN
50
DELISTED
Alexion Pharmaceuticals
ALXN
$925K 0.68%
+5,000
New +$926K

Similar funds

Atika Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Atika Capital Management held 88 positions worth $137M, up 5.2% from $130M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Atika Capital Management withdrew a net $9.94M in Q4 2014, closing 20 positions and reducing 22 holdings. Its most notable exit was Martin Marietta Materials, an estimated $3.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Atika Capital Management opened a new position in Happen Inc worth $2.91M.

  • Atika Capital Management's largest Q4 2014 buy was Happen Inc: 23,000 shares worth $2.91M.
  • Atika Capital Management added most to RECEPTOS INC COM STK (DE) in Q4 2014, an estimated $2.73M increase.
  • Atika Capital Management's biggest Q4 2014 reduction was Agios Pharmaceuticals, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Martin Marietta Materials in Q4 2014, selling an estimated $3.69M.
  • Atika Capital Management's ten largest holdings make up 36% of its $137M portfolio in Q4 2014.
  • Atika Capital Management opened 23 new positions and closed 20 in Q4 2014.
  • Atika Capital Management's portfolio value rose 5.2% quarter-over-quarter to $137M.

Based on Atika Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.